Jun.20,2025
FIMECS organizes “3rd Targeted Protein Degradation Conference in Japan” This July
News release
FIMECS, Inc., a biotechnology company specializing in targeted protein degradation, today announced that it will co-host the 3rd Targeted Protein Degradation Conference in Japan in collaboration with Shonan Health Innovation Park. The international event will take place from July 29th to 31st, 2025, at Shonan iPark in Fujisawa, Kanagawa.
The conference will spotlight the rapidly advancing field of Targeted Protein Degradation (TPD), bringing together global leaders from academia and industry. The keynote address will be delivered by Dr. Gwenn Hanssen, Chief Scientific Officer of Nurix Therapeutics, a pioneering biotech company based in the United States.
In addition to the keynote, the agenda features a distinguished lineup of speakers from pharmaceutical companies, biotech ventures, and academic institutions, who will present on cutting-edge scientific breakthroughs and emerging technologies in TPD.
By facilitating the exchange of the latest insights and promoting collaboration across the TPD community, the conference aims to contribute to shaping the future of drug discovery.
Conference Details
• Title: 3rd Targeted Protein Degradation Conference in Japan
• Dates: July 29th (Tue) – July 31st (Thu), 2025
• Venue: Shonan Health Innovation Park, Fujisawa, Kanagawa, Japan
• Registration: Please visit the official website for details
• Website: https://conference.fimecs.com
For inquiries, please contact:
The Steering Committee of the 3rd Targeted Protein Degradation Conference in Japan
(Representative: FIMECS, Inc.)
Email: tpd@fimecs.com